Stock listing
4516N Stock Price, News, Filings & Events — Nippon Shinyaku Co., Ltd.
Selected listing: 4516N · BIVA · MXN · MX
This page tracks Nippon Shinyaku Co., Ltd.'s 4516N:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4516N:BIVA. 4516N:BIVA is the stock-level entry point for investors researching Nippon Shinyaku Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 4516/N:BIVA
- Asset type
- Stock
- Market cap
- $1.46B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BIVA
- Currency
- MXN
Nippon Shinyaku Co., Ltd. 4516N:BIVA stock context
This page tracks Nippon Shinyaku Co., Ltd.'s 4516N:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4516N:BIVA. 4516N:BIVA is the stock-level entry point for investors researching Nippon Shinyaku Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Nippon Shinyaku Co., Ltd.
Nippon Shinyaku : SAKIGAKE Pharmaceutical Product (Pioneering Drug) Designation Granted to NS-035 for the Treatment of Fukuyama Congenital Muscular Dystrophy
August 26, 2026
Notice Regarding Completion of Disposal of Treasury Stock as Restricted Stock Compensation
August 19, 2026
Nippon Shinyaku : Regarding the U.S. Litigation Concerning CAP-1002 (deramiocel) – U.S. Court Denies Motion for Preliminary Injunction and Refers Dispute to Arbitration
August 9, 2026
Consolidated Financial Results for the First Quarter of Fiscal Year 2026(IFRS)
August 5, 2026
Nippon Shinyaku : Exercises Option Rights for Commercialization of AB2 Bio’s Tadekinig alfa in the U.S.
July 30, 2026
Research Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. investor report
Review AI stock analysis and investor report context for 4516N:BIVA.
Nippon Shinyaku Co., Ltd. company profile
View the public company page for Nippon Shinyaku Co., Ltd. on 6ix.
Nippon Shinyaku Co., Ltd. news
Read company news and market updates connected to Nippon Shinyaku Co., Ltd..
Nippon Shinyaku Co., Ltd. investor events
Find investor webinars, events, and replay context for Nippon Shinyaku Co., Ltd..
Alternate listings
4516:TSE
JP · JPY
Alternate listing for Nippon Shinyaku Co., Ltd.; the primary context on this page is 4516N:BIVA.
NPPNY:OTC
US · USD
Alternate listing for Nippon Shinyaku Co., Ltd.; the primary context on this page is 4516N:BIVA.
NPNKF:OTC
US · USD
Alternate listing for Nippon Shinyaku Co., Ltd.; the primary context on this page is 4516N:BIVA.
4516N:BMV
MX · MXN
Alternate listing for Nippon Shinyaku Co., Ltd.; the primary context on this page is 4516N:BIVA.